Discontinued — last reported Q2 '22
Idexx Laboratories Income Taxes Payable decreased by 9.7% to $80.03M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.5%, from $101.93M to $80.03M. Over 5 years (FY 2020 to FY 2025), Income Taxes Payable shows an upward trend with a 15.7% CAGR.
An increase often reflects higher taxable income, while a decrease may indicate tax payments made or lower taxable earnings.
This represents the current portion of income tax obligations owed to various government taxing authorities based on tax...
Common across all profitable corporations, varying based on effective tax rates and jurisdictional tax laws.
income_taxes_payable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.43M | $43.54M | $42.61M | $84.15M | $22.10M | $34.71M | $48.55M | $72.83M | $56.41M | $50.26M | $86.55M | $134.20M | $146.37M | $80.07M | $62.25M | $101.93M | $75.21M | $89.20M | $88.67M | $80.03M |
| QoQ Change | — | +10.4% | -2.1% | +97.5% | -73.7% | +57.0% | +39.9% | +50.0% | -22.5% | -10.9% | +72.2% | +55.0% | +9.1% | -45.3% | -22.3% | +63.7% | -26.2% | +18.6% | -0.6% | -9.7% |
| YoY Change | — | — | — | — | -43.9% | -20.3% | +13.9% | -13.5% | +155.2% | +44.8% | +78.3% | +84.3% | +159.5% | +59.3% | -28.1% | -24.0% | -48.6% | +11.4% | +42.4% | -21.5% |